Spots Global Cancer Trial Database for Stereotactic Radiotherapy for Cerebral Metastases With Recent Hemorrhagic Signal
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stereotactic Radiotherapy for Cerebral Metastases With Recent Hemorrhagic Signal
Official Title: Stereotactic Radiotherapy for Cerebral Metastases With Recent Hemorrhagic Signal: Phase 2 Study in 2 Steps
Study ID: NCT03696680
Conditions
Interventions
Study Description
Brief Summary: This prospective 2-stage, non-randomized Phase 2 trial evaluates the safety and efficacy of FSRT for the management of hemorrhagic brain metastases
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre de la Baie, Avranches, , France
Centre François Baclesse, Caen, , France
Institut de Cancérologie de Lorraine, Nancy, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
